Email Newsletters

News

Boston Scientific estimates $861M tax bill on foreign earnings

Marlborough medical device maker Boston Scientific is reporting a fourth-quarter loss of $615 million, primarily due to an $861-million tax charge to bring foreign earnings to the U.S.

Waters to take $550M hit from new federal tax plan

Milford laboratory instrument maker Waters Corp. said it estimated a $550-million income tax hit from the new federal tax system, dragging down the 2017 bottom line.

Sunovion announces positive Parkinson’s clinical trial progress

Sunovion Pharmaceuticals of Marlborough said Monday a clinical trial for a treatment for those with Parkinson's disease has brought positive results.

Wayland tax firm opens Shrewsbury location

A Wayland-based tax and accounting practice has opened a second office, along the Boston Turnpike in Shrewsbury, the company announced Monday.
ADVERTISEMENT

J.D. Power donates $3M to alma mater Holy Cross

J.D. Power, known for his namesake awards for cars and other consumer products, has given $3 million to the College of the Holy Cross, his alma mater.

MetroWest office market shrinks in fourth quarter

The total amount of occupied office space in MetroWest fell in the last three months of 2017, negating some of what was otherwise a standout year, according to a new report.

Two of the grocery industry’s unique brands are about to settle in Central Massachusetts

Grocery shopping can be a mundane experience, a get-in-and-get-out exercise not exactly stirring up passion. Then there's Whole Foods Market and Market Basket.

Worcester estate law firm rebrands

After doubling in size and acquiring a Princeton-based law firm, Worcester-based Estate Preservation Law Offices announced a rebranding of the firm.
ADVERTISEMENT

Boost Fitness acquired by NYC fitness chain

Hudson-based Boost Fitness and its eight Massachusetts locations have been acquired by a New York City-based nationwide chain of gyms.

Boston Scientific receives FDA approval for non-opioid painkiller

Boston Scientific announced Thursday it has received regulatory approval for a new treatment for chronic pain without the use of opioids.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA